<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Nyt GSK studie med ofatumumab (nr. 53 i rækken):]]></title><description><![CDATA[<p dir="auto">Nyt GSK studie med ofatumumab (nr. 53 i rækken):</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://clinicaltrials.gov/ct2/show/NCT01294579?term=ofatumumab&amp;rank=2">
301 Moved Permanently
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://clinicaltrials.gov/ct2/show/NCT01294579?term=ofatumumab&amp;rank=2" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://clinicaltrials.gov/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(clinicaltrials.gov)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448324/nyt-gsk-studie-med-ofatumumab-nr-53-i-rkken</link><generator>RSS for Node</generator><lastBuildDate>Sun, 21 Jun 2026 00:56:47 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448324.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 14 Feb 2011 19:39:27 GMT</pubDate><ttl>60</ttl></channel></rss>